5/27 RegenMD

RegenMD         Research and Markets: Molecular Assembly of Biomimetic Systems - State-of-the ... May 26, 2011 at 2:24 PM   Medical applications such as drug release, gene therapy, and tissue engineering as well as biosensing, biocatalysis, and energy storage are highlighted. Junbai Li is a Director of the Key Lab of Colloid and Interface Science, Institute of Chemistry, ... See all stories on this topic »         Read All About It! May 26, 2011 at 2:11 PM         QUANTUM LEAP IN SCIENCE COULD RESTORE HEARING May 26, 2011 at 10:34 AM   A conference, sponsored by the RNID, will see eminent clinicians and scientists from around the world discuss and debate how tissue engineering in the auditory system could transform the lives of deaf people. The event, "Tissue Engineering in the ... See all stories on this topic »         Cell Line Genetics Marks 7500 Quality Assurance Cases in the Field of Stem ... May 26, 2011 at 9:47 AM   "This milestone reflects our leadership in the regenerative medicine QA space, and moreover, speaks to the loyalty of our customers, to our scientific and operational excellence, and to a healthy market demand. We continue to grow as a company and ... See all stories on this topic »         New biomaterial more closely mimics human tissue May 26, 2011 at 9:24 AM   The invention from nanoengineers at the University of California, San Diego marks a significant breakthrough in tissue engineering because it more closely mimics the properties of native human tissue. Shaochen Chen, professor in the Department of ... See all stories on this topic » PhysOrg.com         Poloxamer-188 reduces muscular edema after tourniquet-induced ischemia-reperfusion injury in rats. May 26, 2011 at 9:04 AM   Poloxamer-188 reduces muscular edema after tourniquet-induced ischemia-reperfusion injury in rats. J Trauma. 2011 May;70(5):1192-7 Authors: Walters TJ, Mase VJ, Roe JL, Dubick MA, Christy RJ : Skeletal muscle injury can result in significant edema, which can in turn lead to the development of acute extremity compartment syndrome (CS). Poloxamer-188 (P-188), a multiblock copolymer surfactant, has been shown to decrease edema by sealing damaged membranes in a number of tissues after a variety of injury modalities. The objective is to determine whether the administration of P-188 significantly reduces skeletal muscle edema associated with ischemia/reperfusion injury (I-R). PMID: 21610433 [PubMed - in process]         Reportlinker Adds Future Directions in Regenerative Medicine May 26, 2011 at 7:19 AM   This report covers the development of therapies to replace human cells or promote their regeneration: including cell therapies, tissue engineering, drugs, and medical devices. Each company profiled has at least one project in preclinical or Phase I ... See all stories on this topic »         Kensey Nash sees new opportunities with Norian buy May 26, 2011 at 12:03 AM   By BRIAN MCCULLOUGH UWCHLAN -- Tuesday's purchase of Norian, Synthes Inc.'s troubled subsidiary, will give Kensey Nash Corp. the chance to expand its presence in the regenerative medicine market and improve its bottom line. ... See all stories on this topic »             This email was sent to regenmd@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here